Integrating cognitive behavioral therapy and pharmacotherapy in the treatment of adolescent depression

American Academy of Child and Adolescent Psychiatry, 1998, Practice parameters for the assessment and treatment of children and adolescents with depressive disorders, Journal of the American Academy of Child and Adolescent Psychiatry, 37, 63S Biederman, 1998, Depression in attention deficit hyperactivity disorder (ADHD) children: “True” depression or demoralization?, Journal of Affective Disorders, 47, 113, 10.1016/S0165-0327(97)00127-4 Birmaher, 1998, Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders, Journal of the American Academy of Child & Adolescent Psychiatry, 37, 1234, 10.1097/00004583-199811000-00029 Calabrese, 2001, Bipolar rapid cycling: Focus on depression as its hallmark, Journal of Clinical Psychiatry, 62, 34 Cornelius, 1997, Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial, Archives of General Psychiatry, 54, 700, 10.1001/archpsyc.1997.01830200024004 Curry, 2001, Specific psychotherapies for childhood and adolescent depression, Biological Psychiatry, 49, 1091, 10.1016/S0006-3223(01)01130-1 Emslie, 2002, Efficacy and safety of nefazodone in the treatment of adolescents with major depressive disorder, Journal of Child and Adolescent Psychopharmacology, 12, 299 Emslie, 2001, Fluoxetine for maintenance of recovery from depression in children and adolescents: A placebo-controlled, randomized clinical trial, Journal of Child and Adolescent Psychopharmacology, 11, 328 Emslie, 2002, Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial, Journal of the American Academy of Child & Adolescent Psychiatry, 41, 1205, 10.1097/00004583-200210000-00010 Emslie, 2002, Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial, Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1205, 10.1097/00004583-200210000-00010 Emslie, 1997, Recurrence of major depressive disorder in hospitalized children and adolescents, Journal of the American Academy of Child and Adolescent Psychiatry, 36, 785, 10.1097/00004583-199706000-00015 Emslie, 1997, A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression, Archives of General Psychiatry, 54, 1031, 10.1001/archpsyc.1997.01830230069010 Essau, 1999, Epidemiology of depressive disorders, 69 Findling, 2002, Somatic treatment for depressive illnesses in children and adolescents, Child and Adolescent Psychiatric Clinics of North America, 11, 555, 10.1016/S1056-4993(02)00010-X Findling, 2001, Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder, Bipolar Disorders, 3, 202, 10.1034/j.1399-5618.2001.30405.x Findling, 2002 Findling, 2003, Combination lithium and divalproex sodium in pediatric bipolarity, Journal of the American Academy of Child and Adolescent Psychiatry, 42, 895, 10.1097/01.CHI.0000046893.27264.53 Findling, 2003, An open-label pilot study of St. John's wort in juvenile depression, Journal of the American Academy of Child and Adolescent Psychiatry, 42, 908, 10.1097/01.CHI.0000046900.27264.2A Geller, 1994, Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children, Journal of the American Academy of Child and Adolescent Psychiatry, 33, 461, 10.1097/00004583-199405000-00003 Harrington, 1998, Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder, British Medical Journal, 316, 1559, 10.1136/bmj.316.7144.1559 Hollon, 2005, Treatment of depression in adolescents with cognitive behavior therapy and medications: A commentary on the TADS- project, Cognitive and Behavioral Practice, 12, 149, 10.1016/S1077-7229(05)80019-7 Hoog, 2001, Fluoxetine treatment 20 mg versus 40–60 mg for pediatric fluoxetine 20 mg nonresponders [Abstract] Hutto, 1998, Subtle psychiatric presentations of endocrine diseases, Psychiatric Clinics of North America, 21, 905, 10.1016/S0193-953X(05)70048-4 Kashani, 1987, Psychiatric disorders in a community sample of adolescents, American Journal of Psychiatry, 144, 584 Kashani, 1987, Depression, depressive symptoms, and depressed mood among a community sample of adolescents, American Journal of Psychiatry, 144, 931, 10.1176/ajp.144.7.931 Kaslow, 1998, Applying the criteria for empirically supported treatments to studies of psychosocial interventions for child and adolescent depression, Journal of Clinical Child Psychology, 27, 146, 10.1207/s15374424jccp2702_2 Keller, 2001, Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial, Journal of the American Academy of Child and Adolescent Psychiatry, 40, 762, 10.1097/00004583-200107000-00010 Kennard, 2005, Implementation challenges to TADS cognitive-behavioral therapy, Cognitive and Behavioral Practice, 12, 230, 10.1016/S1077-7229(05)80028-8 Kowatch, 2003, Combination pharmacotherapy in children and adolescents with bipolar disorder, Biological Psychiatry, 53, 978, 10.1016/S0006-3223(03)00067-2 Kraepelin, 1921, Manic-depressive insanity and paranoia, 10.1097/00005053-192104000-00057 Lewinsohn, 1999, Psychosocial treatments for adolescent depression, Clinical Psychology Review, 19, 329, 10.1016/S0272-7358(98)00055-5 Lewinsohn, 1993, Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students, Journal of Abnormal Psychology, 102, 133, 10.1037/0021-843X.102.1.133 March, 2003, Combining medication and psychotherapy, 426 McGuffin, 2003, The heritability of bipolar affective disorder and the genetic relationship to unipolar depression, Archives of General Psychiatry, 60, 497, 10.1001/archpsyc.60.5.497 Medicines and Healthcare Products Regulatory Agency, 2003 Papolos, 2003, Switching, cycling, and antidepressant-induced effects on cycle frequency and course of illness in adult bipolar disorder: a brief review and commentary, Journal of Child and Adolescent Psychopharmacology, 13, 165, 10.1089/104454603322163880 Pies, 1994, Medical “mimics” of depression, Psychiatric Annals, 24, 519, 10.3928/0048-5713-19941001-08 Reinecke, 1998, Cognitive-behavioral therapy of depression and depressive symptoms during adolescence: A review and meta-analysis, Journal of the American Academy of Child & Adolescent Psychiatry, 37, 26, 10.1097/00004583-199801000-00013 Rogers, 2005, Case formulation in TADS CBT, Cognitive and Behavioral Practice, 12, 198, 10.1016/S1077-7229(05)80025-2 Strober, 1993, The course of major depressive disorder in adolescents: I. Recovery and risk of manic switching in a follow-up of psychotic and non-psychotic subtypes, Journal of the American Academy of Child and Adolescent Psychiatry, 32, 34, 10.1097/00004583-199301000-00006 Treatment for Adolescents With Depression Study Team, 2003, Treatment for adolescents with depression study (TADS): Rationale, design, and methods, Journal of the American Academy of Child & Adolescent Psychiatry, 42, 531, 10.1097/01.CHI.0000046839.90931.0D Treatment for Adolescents with Depression Study Team, 2004, Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial, Journal of the American Medical Association, 292, 807, 10.1001/jama.292.7.807 U.S. Food and Drug Administration, 2003 U.S. Food and Drug Administration, 2003 U.S. Food and Drug Administration, 2003 Wagner, 2003, Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: Two randomized controlled trials, Journal of the American Medical Association, 290, 1033, 10.1001/jama.290.8.1033 Wagner, 2002, Citalopram is effective in the treatment of major depressive disorder in children and adolescents: Results of a placebo-controlled trial, International Journal of Neuropsychopharmacology, 5, S 161 Wells, 2005, Parent involvement in CBT treatment of adolescent depression: Experiences in the Treatment for Adolescents With Depression Study (TADS), Cognitive and Behavioral Practice, 12, 209, 10.1016/S1077-7229(05)80026-4 Wisner, 2000, Risk-benefit decision making for treatment of depression during pregnancy, American Journal of Psychiatry, 157, 1933, 10.1176/appi.ajp.157.12.1933